0001225208-24-007005.txt : 20240626 0001225208-24-007005.hdr.sgml : 20240626 20240626170709 ACCESSION NUMBER: 0001225208-24-007005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240624 FILED AS OF DATE: 20240626 DATE AS OF CHANGE: 20240626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Evanko Brian C CENTRAL INDEX KEY: 0001722909 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38769 FILM NUMBER: 241074441 MAIL ADDRESS: STREET 1: 1601 CHESTNUT STREET STREET 2: SHAREHOLDER SERVICES TL05Y CITY: PHILADELPHIA STATE: PA ZIP: 19192 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cigna Group CENTRAL INDEX KEY: 0001739940 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 824991898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602266000 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: Cigna Corp DATE OF NAME CHANGE: 20181221 FORMER COMPANY: FORMER CONFORMED NAME: Halfmoon Parent, Inc. DATE OF NAME CHANGE: 20180508 4 1 doc4.xml X0508 4 2024-06-24 0001739940 Cigna Group CI 0001722909 Evanko Brian C 900 COTTAGE GROVE ROAD BLOOMFIELD CT 06002 1 See Remarks 1 Common Stock, $.01 Par Value 2024-06-24 4 M 0 4795.0000 120.8950 A 44718.0000 D Common Stock, $.01 Par Value 2024-06-24 4 S 0 4795.0000 345.0058 D 39923.0000 D Common Stock, $.01 Par Value 2024-06-25 4 M 0 1011.0000 120.8950 A 40934.0000 D Common Stock, $.01 Par Value 883.1588 I By 401(k) Employee Stock Option (Right to Buy) 120.8950 2024-06-24 4 M 0 4795.0000 0.0000 D 2016-02-25 2025-02-25 Common Stock, $.01 Par Value 4795.0000 1011.0000 D Employee Stock Option (Right to Buy) 120.8950 2024-06-25 4 M 0 1011.0000 0.0000 D 2016-02-25 2025-02-25 Common Stock, $.01 Par Value 1011.0000 0.0000 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2024. Represents the weighted average price of the shares sold. The prices actually received ranged from $345.00 to $345.07 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range. Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan. This option was granted on February 25, 2015. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date. EVP, Chief Financial Officer and President & CEO, Cigna Healthcare Matthew Arnold, attorney-in-fact 2024-06-25